Antiretroviral therapies work to help stop replication of the HIV virus in the body and can reduce the viral load to a point ...

HONG KONG SAR - Media OutReach Newswire – 12 November 2024 - Immuno Cure BioTech (" Immuno Cure "), a clinical-stage ...

The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver ...

Efficacy based on baseline viral load categories was comparable between both treatment ... “We know taking fewer medicines is ...

The sex of people living with HIV-1 infection, schistosome infection, or both, is a fundamental determinant of their clinical ...

Highly effective treatments for HIV have existed since the mid-1990s. But while these treatments keep people healthy, we do not yet have a safe and scalable way to completely rid the body of the virus ...

As the science stands, the vast majority of the roughly eight million people in South Africa living with HIV will have to get ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today ...

A pop-up sexual health clinic has seen an increase in the number of new people coming forward to get tested for HIV. The ...

At eight weeks, the viral load of HIV declined in all participants and death of the infected cells was observed. Due to ...

A post-hoc analysis of the study showed DTG/3TC was non-inferior to 3-drug therapy regardless of the participant’s baseline viral load. These data were presented at HIV Glasgow 2024, being held in ...

Immuno Cure is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development ...